epoetin alfa 中文意思是什麼
-
Patients received 20, 000 iu of epoetin alfa subcutaneously every 2 wk for up to 27 wk, with dosage adjustments permitted after 4 wk of treatment
病人每兩周接受1次重組人紅細胞生成素皮下注射，直到第27周，在用藥第4周后允許對用藥量進行調整。 -
This open - label, multicenter, single - arm study investigated the efficacy of administration of 20, 000 iu of epoetin alfa once every 2 wk as initiation therapy in these patients
這個標簽公開，多中心，單一目的的試驗觀察在起始治療階段每兩周注射1次重組人紅細胞生成素20 ， 000iu的效果。 -
There are limited data suggesting that initiation of epoetin alfa at extended dosing intervals of every 2, 3, or 4 wk may be efficacious for treating anemia in patients who have chronic kidney disease and are not on dialysis ( ckd - nod )
有限的資料顯示：擴大初始的給藥間隔時間到2 ， 3 ，或者4周，對應用重組人紅細胞生成素治療慢性腎臟病未透析患者（ ckd - nod ）的貧血是有效的。
分享友人